Ardelyx Inc (ARDX)
6.65
+0.29
(+4.56%)
USD |
NASDAQ |
Sep 27, 16:00
6.73
+0.08
(+1.20%)
Pre-Market: 20:00
Ardelyx SG&A Expense (TTM): 198.06M for June 30, 2024
SG&A Expense (TTM) Chart
Historical SG&A Expense (TTM) Data
Date | Value |
---|---|
June 30, 2024 | 198.06M |
March 31, 2024 | 160.59M |
December 31, 2023 | 134.40M |
September 30, 2023 | 106.38M |
June 30, 2023 | 92.39M |
March 31, 2023 | 84.06M |
December 31, 2022 | 76.60M |
September 30, 2022 | 72.20M |
June 30, 2022 | 73.25M |
March 31, 2022 | 74.51M |
December 31, 2021 | 72.30M |
September 30, 2021 | 68.31M |
June 30, 2021 | 56.23M |
March 31, 2021 | 43.15M |
December 31, 2020 | 33.15M |
September 30, 2020 | 28.67M |
June 30, 2020 | 27.96M |
March 31, 2020 | 26.29M |
December 31, 2019 | 24.27M |
September 30, 2019 | 22.84M |
June 30, 2019 | 21.87M |
March 31, 2019 | 22.64M |
Date | Value |
---|---|
December 31, 2018 | 23.72M |
September 30, 2018 | 23.77M |
June 30, 2018 | 23.67M |
March 31, 2018 | 23.38M |
December 31, 2017 | 23.23M |
September 30, 2017 | 23.02M |
June 30, 2017 | 21.50M |
March 31, 2017 | 20.50M |
December 31, 2016 | 18.73M |
September 30, 2016 | 17.56M |
June 30, 2016 | 16.60M |
March 31, 2016 | 14.63M |
December 31, 2015 | 13.53M |
September 30, 2015 | 12.32M |
June 30, 2015 | 10.77M |
March 31, 2015 | 9.087M |
December 31, 2014 | 7.289M |
September 30, 2014 | 5.273M |
June 30, 2014 | 4.345M |
March 31, 2014 | 4.05M |
December 31, 2013 | 3.70M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (TTM) Range, Past 5 Years
22.84M
Minimum
Sep 2019
198.06M
Maximum
Jun 2024
73.78M
Average
72.25M
Median
SG&A Expense (TTM) Benchmarks
Enanta Pharmaceuticals Inc | 57.96M |
Sage Therapeutics Inc | 241.81M |
NovaBay Pharmaceuticals Inc | 11.53M |
Palatin Technologies Inc | 13.34M |
iBio Inc | 11.67M |